Scholarlink

Intermediate-risk prostate cancer usually carries a good prognosis. The treatment options for these patients include radiotherapy (RT) with short-term androgen deprivation therapy (ADT) or radical prostatectomy (RP). Active surveillance (AS) is an alternative to definitive treatment in favourable intermediate-risk cancer patients with limited life expectancy.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Intermediate-Risk Prostate Cancer: A Guide for Radiation Oncologists

  • 章节

  • 发表日期：

    2026年

查看全文
  • K. N. Yousra Izzuddeen,
  • Adila Amariyil

摘要

Intermediate-risk prostate cancer usually carries a good prognosis. The treatment options for these patients include radiotherapy (RT) with short-term androgen deprivation therapy (ADT) or radical prostatectomy (RP). Active surveillance (AS) is an alternative to definitive treatment in favourable intermediate-risk cancer patients with limited life expectancy.